Nerve Stimulator Co. Again Beats Investor Suit Over $78M IPO

By Emilie Ruscoe (July 14, 2023, 6:08 PM EDT) -- An investor in bioelectronic medicine company electroCore Inc. will have one final shot at revising her proposed class action alleging that the company misrepresented the types and scope of agreements the company had in place with commercial health insurance companies in the lead-up to its $77.7 million initial public offering in June 2018, a New Jersey federal judge has decided....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!